Semaglutide’s weight loss benefits fade after stopping treatment
Semaglutide, a drug used in medications like Wegovy, Ozempic, and Rybelsus, has gained attention for its role in weight loss. While Wegovy is the only version officially approved for this purpose in the U.S., many people also use Ozempic and Rybelsus off-label. However, stopping the treatment often leads to weight regain, raising questions about long-term effectiveness.
Semaglutide works by suppressing appetite and increasing feelings of fullness. As a glucagon-like peptide-1 (GLP-1) receptor agonist, it also helps balance blood sugar levels. Wegovy is FDA-approved for weight loss and reducing cardiovascular disease risk, while Ozempic and Rybelsus are primarily prescribed for managing type 2 diabetes.
Semaglutide offers a way to lose weight, but its effects often fade after stopping the drug. Those looking for lasting results may need to pair it with ongoing support from healthcare professionals and healthy habits. Without these steps, weight regain remains a common challenge for many users.
